Global Axial Spondyloarthritis Drugs Market Research Report 2023

The global Axial Spondyloarthritis Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Axial Spondyloarthritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Axial Spondyloarthritis Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Axial Spondyloarthritis Drugs include AstraZeneca Plc, Eli Lilly and Company, Johnson & Johnson, Novartis AG, Panacea Biotec Ltd, Sandoz International GmbH, Sun Pharma Advanced Research Company Ltd and UCB SA, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Axial Spondyloarthritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Axial Spondyloarthritis Drugs.

The Axial Spondyloarthritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Axial Spondyloarthritis Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Axial Spondyloarthritis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Axial Spondyloarthritis Drugs

1.2 Axial Spondyloarthritis Drugs Segment by Type

1.2.1 Global Axial Spondyloarthritis Drugs Market Value Comparison by Type (2023-2029)

1.2.2 Certolizumab Pegol

1.2.3 Etanercept Biosimilar

1.2.4 Ixekizumab

1.2.5 Secukinumab

1.2.6 Others

1.3 Axial Spondyloarthritis Drugs Segment by Application

1.3.1 Global Axial Spondyloarthritis Drugs Market Value by Application: (2023-2029)

1.3.2 Clinic

1.3.3 Hospital

1.3.4 Home Care

1.4 Global Axial Spondyloarthritis Drugs Market Size Estimates and Forecasts

1.4.1 Global Axial Spondyloarthritis Drugs Revenue 2018-2029

1.4.2 Global Axial Spondyloarthritis Drugs Sales 2018-2029

1.4.3 Global Axial Spondyloarthritis Drugs Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Axial Spondyloarthritis Drugs Sales Market Share by Manufacturers (2018-2023)

2.2 Global Axial Spondyloarthritis Drugs Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Axial Spondyloarthritis Drugs Average Price by Manufacturers (2018-2023)

2.4 Global Axial Spondyloarthritis Drugs Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Axial Spondyloarthritis Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Axial Spondyloarthritis Drugs, Product Type & Application

2.7 Axial Spondyloarthritis Drugs Market Competitive Situation and Trends

2.7.1 Axial Spondyloarthritis Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Axial Spondyloarthritis Drugs Players Market Share by Revenue

2.7.3 Global Axial Spondyloarthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Axial Spondyloarthritis Drugs Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Axial Spondyloarthritis Drugs Global Axial Spondyloarthritis Drugs Sales by Region: 2018-2029

3.2.1 Global Axial Spondyloarthritis Drugs Sales by Region: 2018-2023

3.2.2 Global Axial Spondyloarthritis Drugs Sales by Region: 2024-2029

3.3 Global Axial Spondyloarthritis Drugs Global Axial Spondyloarthritis Drugs Revenue by Region: 2018-2029

3.3.1 Global Axial Spondyloarthritis Drugs Revenue by Region: 2018-2023

3.3.2 Global Axial Spondyloarthritis Drugs Revenue by Region: 2024-2029

3.4 North America Axial Spondyloarthritis Drugs Market Facts & Figures by Country

3.4.1 North America Axial Spondyloarthritis Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Axial Spondyloarthritis Drugs Sales by Country (2018-2029)

3.4.3 North America Axial Spondyloarthritis Drugs Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Axial Spondyloarthritis Drugs Market Facts & Figures by Country

3.5.1 Europe Axial Spondyloarthritis Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Axial Spondyloarthritis Drugs Sales by Country (2018-2029)

3.5.3 Europe Axial Spondyloarthritis Drugs Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Axial Spondyloarthritis Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Axial Spondyloarthritis Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Axial Spondyloarthritis Drugs Sales by Country (2018-2029)

3.6.3 Asia Pacific Axial Spondyloarthritis Drugs Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Axial Spondyloarthritis Drugs Market Facts & Figures by Country

3.7.1 Latin America Axial Spondyloarthritis Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Axial Spondyloarthritis Drugs Sales by Country (2018-2029)

3.7.3 Latin America Axial Spondyloarthritis Drugs Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Axial Spondyloarthritis Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Axial Spondyloarthritis Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Axial Spondyloarthritis Drugs Sales by Country (2018-2029)

3.8.3 Middle East and Africa Axial Spondyloarthritis Drugs Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Axial Spondyloarthritis Drugs Sales by Type (2018-2029)

4.1.1 Global Axial Spondyloarthritis Drugs Sales by Type (2018-2023)

4.1.2 Global Axial Spondyloarthritis Drugs Sales by Type (2024-2029)

4.1.3 Global Axial Spondyloarthritis Drugs Sales Market Share by Type (2018-2029)

4.2 Global Axial Spondyloarthritis Drugs Revenue by Type (2018-2029)

4.2.1 Global Axial Spondyloarthritis Drugs Revenue by Type (2018-2023)

4.2.2 Global Axial Spondyloarthritis Drugs Revenue by Type (2024-2029)

4.2.3 Global Axial Spondyloarthritis Drugs Revenue Market Share by Type (2018-2029)

4.3 Global Axial Spondyloarthritis Drugs Price by Type (2018-2029)

5.1 Global Axial Spondyloarthritis Drugs Sales by Application (2018-2029)

5.1.1 Global Axial Spondyloarthritis Drugs Sales by Application (2018-2023)

5.1.2 Global Axial Spondyloarthritis Drugs Sales by Application (2024-2029)

5.1.3 Global Axial Spondyloarthritis Drugs Sales Market Share by Application (2018-2029)

5.2 Global Axial Spondyloarthritis Drugs Revenue by Application (2018-2029)

5.2.1 Global Axial Spondyloarthritis Drugs Revenue by Application (2018-2023)

5.2.2 Global Axial Spondyloarthritis Drugs Revenue by Application (2024-2029)

5.2.3 Global Axial Spondyloarthritis Drugs Revenue Market Share by Application (2018-2029)

5.3 Global Axial Spondyloarthritis Drugs Price by Application (2018-2029)

6.1 AstraZeneca Plc

6.1.1 AstraZeneca Plc Corporation Information

6.1.2 AstraZeneca Plc Description and Business Overview

6.1.3 AstraZeneca Plc Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2018-2023)

6.1.4 AstraZeneca Plc Axial Spondyloarthritis Drugs Product Portfolio

6.1.5 AstraZeneca Plc Recent Developments/Updates

6.2 Eli Lilly and Company

6.2.1 Eli Lilly and Company Corporation Information

6.2.2 Eli Lilly and Company Description and Business Overview

6.2.3 Eli Lilly and Company Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Eli Lilly and Company Axial Spondyloarthritis Drugs Product Portfolio

6.2.5 Eli Lilly and Company Recent Developments/Updates

6.3 Johnson & Johnson

6.3.1 Johnson & Johnson Corporation Information

6.3.2 Johnson & Johnson Description and Business Overview

6.3.3 Johnson & Johnson Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Johnson & Johnson Axial Spondyloarthritis Drugs Product Portfolio

6.3.5 Johnson & Johnson Recent Developments/Updates

6.4 Novartis AG

6.4.1 Novartis AG Corporation Information

6.4.2 Novartis AG Description and Business Overview

6.4.3 Novartis AG Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Novartis AG Axial Spondyloarthritis Drugs Product Portfolio

6.4.5 Novartis AG Recent Developments/Updates

6.5 Panacea Biotec Ltd

6.5.1 Panacea Biotec Ltd Corporation Information

6.5.2 Panacea Biotec Ltd Description and Business Overview

6.5.3 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Product Portfolio

6.5.5 Panacea Biotec Ltd Recent Developments/Updates

6.6 Sandoz International GmbH

6.6.1 Sandoz International GmbH Corporation Information

6.6.2 Sandoz International GmbH Description and Business Overview

6.6.3 Sandoz International GmbH Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Sandoz International GmbH Axial Spondyloarthritis Drugs Product Portfolio

6.6.5 Sandoz International GmbH Recent Developments/Updates

6.7 Sun Pharma Advanced Research Company Ltd

6.6.1 Sun Pharma Advanced Research Company Ltd Corporation Information

6.6.2 Sun Pharma Advanced Research Company Ltd Description and Business Overview

6.6.3 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Product Portfolio

6.7.5 Sun Pharma Advanced Research Company Ltd Recent Developments/Updates

6.8 UCB SA

6.8.1 UCB SA Corporation Information

6.8.2 UCB SA Description and Business Overview

6.8.3 UCB SA Axial Spondyloarthritis Drugs Sales, Revenue and Gross Margin (2018-2023)

6.8.4 UCB SA Axial Spondyloarthritis Drugs Product Portfolio

6.8.5 UCB SA Recent Developments/Updates

7.1 Axial Spondyloarthritis Drugs Industry Chain Analysis

7.2 Axial Spondyloarthritis Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Axial Spondyloarthritis Drugs Production Mode & Process

7.4 Axial Spondyloarthritis Drugs Sales and Marketing

7.4.1 Axial Spondyloarthritis Drugs Sales Channels

7.4.2 Axial Spondyloarthritis Drugs Distributors

7.5 Axial Spondyloarthritis Drugs Customers

8.1 Axial Spondyloarthritis Drugs Industry Trends

8.2 Axial Spondyloarthritis Drugs Market Drivers

8.3 Axial Spondyloarthritis Drugs Market Challenges

8.4 Axial Spondyloarthritis Drugs Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Axial Spondyloarthritis Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Axial Spondyloarthritis Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Axial Spondyloarthritis Drugs Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Axial Spondyloarthritis Drugs Sales (K Pcs) of Key Manufacturers (2018-2023)

    Table 5. Global Axial Spondyloarthritis Drugs Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Axial Spondyloarthritis Drugs Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Axial Spondyloarthritis Drugs Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Axial Spondyloarthritis Drugs Average Price (USD/Pcs) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Axial Spondyloarthritis Drugs, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Axial Spondyloarthritis Drugs, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Axial Spondyloarthritis Drugs, Product Type & Application

    Table 12. Global Key Manufacturers of Axial Spondyloarthritis Drugs, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Axial Spondyloarthritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Axial Spondyloarthritis Drugs as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Axial Spondyloarthritis Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Axial Spondyloarthritis Drugs Sales by Region (2018-2023) & (K Pcs)

    Table 18. Global Axial Spondyloarthritis Drugs Sales Market Share by Region (2018-2023)

    Table 19. Global Axial Spondyloarthritis Drugs Sales by Region (2024-2029) & (K Pcs)

    Table 20. Global Axial Spondyloarthritis Drugs Sales Market Share by Region (2024-2029)

    Table 21. Global Axial Spondyloarthritis Drugs Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Axial Spondyloarthritis Drugs Revenue Market Share by Region (2018-2023)

    Table 23. Global Axial Spondyloarthritis Drugs Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Axial Spondyloarthritis Drugs Revenue Market Share by Region (2024-2029)

    Table 25. North America Axial Spondyloarthritis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Axial Spondyloarthritis Drugs Sales by Country (2018-2023) & (K Pcs)

    Table 27. North America Axial Spondyloarthritis Drugs Sales by Country (2024-2029) & (K Pcs)

    Table 28. North America Axial Spondyloarthritis Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Axial Spondyloarthritis Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Axial Spondyloarthritis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Axial Spondyloarthritis Drugs Sales by Country (2018-2023) & (K Pcs)

    Table 32. Europe Axial Spondyloarthritis Drugs Sales by Country (2024-2029) & (K Pcs)

    Table 33. Europe Axial Spondyloarthritis Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Axial Spondyloarthritis Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Axial Spondyloarthritis Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Axial Spondyloarthritis Drugs Sales by Region (2018-2023) & (K Pcs)

    Table 37. Asia Pacific Axial Spondyloarthritis Drugs Sales by Region (2024-2029) & (K Pcs)

    Table 38. Asia Pacific Axial Spondyloarthritis Drugs Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Axial Spondyloarthritis Drugs Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Axial Spondyloarthritis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Axial Spondyloarthritis Drugs Sales by Country (2018-2023) & (K Pcs)

    Table 42. Latin America Axial Spondyloarthritis Drugs Sales by Country (2024-2029) & (K Pcs)

    Table 43. Latin America Axial Spondyloarthritis Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Axial Spondyloarthritis Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Axial Spondyloarthritis Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Axial Spondyloarthritis Drugs Sales by Country (2018-2023) & (K Pcs)

    Table 47. Middle East & Africa Axial Spondyloarthritis Drugs Sales by Country (2024-2029) & (K Pcs)

    Table 48. Middle East & Africa Axial Spondyloarthritis Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Axial Spondyloarthritis Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Axial Spondyloarthritis Drugs Sales (K Pcs) by Type (2018-2023)

    Table 51. Global Axial Spondyloarthritis Drugs Sales (K Pcs) by Type (2024-2029)

    Table 52. Global Axial Spondyloarthritis Drugs Sales Market Share by Type (2018-2023)

    Table 53. Global Axial Spondyloarthritis Drugs Sales Market Share by Type (2024-2029)

    Table 54. Global Axial Spondyloarthritis Drugs Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Axial Spondyloarthritis Drugs Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Axial Spondyloarthritis Drugs Revenue Market Share by Type (2018-2023)

    Table 57. Global Axial Spondyloarthritis Drugs Revenue Market Share by Type (2024-2029)

    Table 58. Global Axial Spondyloarthritis Drugs Price (USD/Pcs) by Type (2018-2023)

    Table 59. Global Axial Spondyloarthritis Drugs Price (USD/Pcs) by Type (2024-2029)

    Table 60. Global Axial Spondyloarthritis Drugs Sales (K Pcs) by Application (2018-2023)

    Table 61. Global Axial Spondyloarthritis Drugs Sales (K Pcs) by Application (2024-2029)

    Table 62. Global Axial Spondyloarthritis Drugs Sales Market Share by Application (2018-2023)

    Table 63. Global Axial Spondyloarthritis Drugs Sales Market Share by Application (2024-2029)

    Table 64. Global Axial Spondyloarthritis Drugs Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Axial Spondyloarthritis Drugs Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Axial Spondyloarthritis Drugs Revenue Market Share by Application (2018-2023)

    Table 67. Global Axial Spondyloarthritis Drugs Revenue Market Share by Application (2024-2029)

    Table 68. Global Axial Spondyloarthritis Drugs Price (USD/Pcs) by Application (2018-2023)

    Table 69. Global Axial Spondyloarthritis Drugs Price (USD/Pcs) by Application (2024-2029)

    Table 70. AstraZeneca Plc Corporation Information

    Table 71. AstraZeneca Plc Description and Business Overview

    Table 72. AstraZeneca Plc Axial Spondyloarthritis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 73. AstraZeneca Plc Axial Spondyloarthritis Drugs Product

    Table 74. AstraZeneca Plc Recent Developments/Updates

    Table 75. Eli Lilly and Company Corporation Information

    Table 76. Eli Lilly and Company Description and Business Overview

    Table 77. Eli Lilly and Company Axial Spondyloarthritis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 78. Eli Lilly and Company Axial Spondyloarthritis Drugs Product

    Table 79. Eli Lilly and Company Recent Developments/Updates

    Table 80. Johnson & Johnson Corporation Information

    Table 81. Johnson & Johnson Description and Business Overview

    Table 82. Johnson & Johnson Axial Spondyloarthritis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 83. Johnson & Johnson Axial Spondyloarthritis Drugs Product

    Table 84. Johnson & Johnson Recent Developments/Updates

    Table 85. Novartis AG Corporation Information

    Table 86. Novartis AG Description and Business Overview

    Table 87. Novartis AG Axial Spondyloarthritis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 88. Novartis AG Axial Spondyloarthritis Drugs Product

    Table 89. Novartis AG Recent Developments/Updates

    Table 90. Panacea Biotec Ltd Corporation Information

    Table 91. Panacea Biotec Ltd Description and Business Overview

    Table 92. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 93. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Product

    Table 94. Panacea Biotec Ltd Recent Developments/Updates

    Table 95. Sandoz International GmbH Corporation Information

    Table 96. Sandoz International GmbH Description and Business Overview

    Table 97. Sandoz International GmbH Axial Spondyloarthritis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 98. Sandoz International GmbH Axial Spondyloarthritis Drugs Product

    Table 99. Sandoz International GmbH Recent Developments/Updates

    Table 100. Sun Pharma Advanced Research Company Ltd Corporation Information

    Table 101. Sun Pharma Advanced Research Company Ltd Description and Business Overview

    Table 102. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 103. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Product

    Table 104. Sun Pharma Advanced Research Company Ltd Recent Developments/Updates

    Table 105. UCB SA Corporation Information

    Table 106. UCB SA Description and Business Overview

    Table 107. UCB SA Axial Spondyloarthritis Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 108. UCB SA Axial Spondyloarthritis Drugs Product

    Table 109. UCB SA Recent Developments/Updates

    Table 110. Key Raw Materials Lists

    Table 111. Raw Materials Key Suppliers Lists

    Table 112. Axial Spondyloarthritis Drugs Distributors List

    Table 113. Axial Spondyloarthritis Drugs Customers List

    Table 114. Axial Spondyloarthritis Drugs Market Trends

    Table 115. Axial Spondyloarthritis Drugs Market Drivers

    Table 116. Axial Spondyloarthritis Drugs Market Challenges

    Table 117. Axial Spondyloarthritis Drugs Market Restraints

    Table 118. Research Programs/Design for This Report

    Table 119. Key Data Information from Secondary Sources

    Table 120. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Axial Spondyloarthritis Drugs

    Figure 2. Global Axial Spondyloarthritis Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Axial Spondyloarthritis Drugs Market Share by Type in 2022 & 2029

    Figure 4. Certolizumab Pegol Product Picture

    Figure 5. Etanercept Biosimilar Product Picture

    Figure 6. Ixekizumab Product Picture

    Figure 7. Secukinumab Product Picture

    Figure 8. Others Product Picture

    Figure 9. Global Axial Spondyloarthritis Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Axial Spondyloarthritis Drugs Market Share by Application in 2022 & 2029

    Figure 11. Clinic

    Figure 12. Hospital

    Figure 13. Home Care

    Figure 14. Global Axial Spondyloarthritis Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Axial Spondyloarthritis Drugs Market Size (2018-2029) & (US$ Million)

    Figure 16. Global Axial Spondyloarthritis Drugs Sales (2018-2029) & (K Pcs)

    Figure 17. Global Axial Spondyloarthritis Drugs Average Price (USD/Pcs) & (2018-2029)

    Figure 18. Axial Spondyloarthritis Drugs Report Years Considered

    Figure 19. Axial Spondyloarthritis Drugs Sales Share by Manufacturers in 2022

    Figure 20. Global Axial Spondyloarthritis Drugs Revenue Share by Manufacturers in 2022

    Figure 21. The Global 5 and 10 Largest Axial Spondyloarthritis Drugs Players: Market Share by Revenue in 2022

    Figure 22. Axial Spondyloarthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 23. Global Axial Spondyloarthritis Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 24. North America Axial Spondyloarthritis Drugs Sales Market Share by Country (2018-2029)

    Figure 25. North America Axial Spondyloarthritis Drugs Revenue Market Share by Country (2018-2029)

    Figure 26. U.S. Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Canada Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. Europe Axial Spondyloarthritis Drugs Sales Market Share by Country (2018-2029)

    Figure 29. Europe Axial Spondyloarthritis Drugs Revenue Market Share by Country (2018-2029)

    Figure 30. Germany Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. France Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. U.K. Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Italy Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Russia Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Asia Pacific Axial Spondyloarthritis Drugs Sales Market Share by Region (2018-2029)

    Figure 36. Asia Pacific Axial Spondyloarthritis Drugs Revenue Market Share by Region (2018-2029)

    Figure 37. China Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Japan Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. South Korea Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. India Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Australia Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Taiwan Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Indonesia Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Thailand Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Malaysia Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Philippines Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Latin America Axial Spondyloarthritis Drugs Sales Market Share by Country (2018-2029)

    Figure 48. Latin America Axial Spondyloarthritis Drugs Revenue Market Share by Country (2018-2029)

    Figure 49. Mexico Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Brazil Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Argentina Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Middle East & Africa Axial Spondyloarthritis Drugs Sales Market Share by Country (2018-2029)

    Figure 53. Middle East & Africa Axial Spondyloarthritis Drugs Revenue Market Share by Country (2018-2029)

    Figure 54. Turkey Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Saudi Arabia Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 56. UAE Axial Spondyloarthritis Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. Global Sales Market Share of Axial Spondyloarthritis Drugs by Type (2018-2029)

    Figure 58. Global Revenue Market Share of Axial Spondyloarthritis Drugs by Type (2018-2029)

    Figure 59. Global Axial Spondyloarthritis Drugs Price (USD/Pcs) by Type (2018-2029)

    Figure 60. Global Sales Market Share of Axial Spondyloarthritis Drugs by Application (2018-2029)

    Figure 61. Global Revenue Market Share of Axial Spondyloarthritis Drugs by Application (2018-2029)

    Figure 62. Global Axial Spondyloarthritis Drugs Price (USD/Pcs) by Application (2018-2029)

    Figure 63. Axial Spondyloarthritis Drugs Value Chain

    Figure 64. Axial Spondyloarthritis Drugs Production Process

    Figure 65. Channels of Distribution (Direct Vs Distribution)

    Figure 66. Distributors Profiles

    Figure 67. Bottom-up and Top-down Approaches for This Report

    Figure 68. Data Triangulation

    Figure 69. Key Executives Interviewed